Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alain Bitton

Showing results (41-50 of 200) with videos related to

Pageof 20
Sort By:
Digestive Diseases and Sciences|June 28, 2020
Poor Drug Sustainability in Inflammatory Bowel Disease Patients in Clinical Remission on Thiopurine MonotherapyBhairavi Balram, Joshua Lubov, Yves Theoret, et al.
Canadian Journal of Gastroenterology & Hepatology|March 9, 2017
Treatment Algorithm for Chronic Idiopathic Constipation and Constipation-Predominant Irritable Bowel Syndrome Derived from a Canadian National Survey and Needs Assessment on Choices of Therapeutic AgentsYvonne Tse, David Armstrong, Christopher N Andrews, et al.
The American Journal of Gastroenterology|July 23, 2003
Patient nonadherence to medication in inflammatory bowel diseaseMaida J Sewitch, Michal Abrahamowicz, Alan Barkun, et al.
Journal of Crohn'S & Colitis|October 30, 2018
Reply to Letter on: 'Risk Factors Associated With Clostridium difficile Infection in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis'Bhairavi Balram, Robert Battat, Alex Al-Khoury, et al.
Public Health Genomics|August 17, 2017
Exploring the Use of a Participative Design in the Early Development of a Predictive Test: The Importance of Physician InvolvementSophie Veilleux, Maude Villeneuve, Nathalie Lachapelle, et al.
Journal of Crohn'S & Colitis|September 25, 2018
Risk Factors Associated with Clostridium difficile Infection in Inflammatory Bowel Disease: A Systematic Review and Meta-AnalysisBhairavi Balram, Robert Battat, Alex Al-Khoury, et al.
Inflammatory Bowel Diseases|October 24, 2008
Epidemiology of Crohn's disease in Québec, CanadaAnne-Marie Lowe, Pierre-Olivier Roy, Michel B-Poulin, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 3, 2017
Association Between Ustekinumab Trough Concentrations and Clinical, Biomarker, and Endoscopic Outcomes in Patients With Crohn's DiseaseRobert Battat, Uri Kopylov, Talat Bessissow, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|October 10, 2013
Overview of subsequent entry biologics for the management of inflammatory bowel disease and Canadian Association of Gastroenterology position statement on subsequent entry biologicsShane M Devlin, Brian Bressler, Charles N Bernstein, et al.
Saudi Journal of Gastroenterology : Official Journal of the Saudi Gastroenterology Association|March 23, 2019
Maladaptive coping, low self-efficacy and disease activity are associated with poorer patient-reported outcomes in inflammatory bowel diseaseChe-Yung Chao, Carolyne Lemieux, Sophie Restellini, et al.
Pageof 20

Showing results (41-50 of 200) with videos related to

Sort By:
Pageof 20
Digestive Diseases and Sciences|June 28, 2020
Poor Drug Sustainability in Inflammatory Bowel Disease Patients in Clinical Remission on Thiopurine MonotherapyBhairavi Balram, Joshua Lubov, Yves Theoret, et al.
Canadian Journal of Gastroenterology & Hepatology|March 9, 2017
Treatment Algorithm for Chronic Idiopathic Constipation and Constipation-Predominant Irritable Bowel Syndrome Derived from a Canadian National Survey and Needs Assessment on Choices of Therapeutic AgentsYvonne Tse, David Armstrong, Christopher N Andrews, et al.
The American Journal of Gastroenterology|July 23, 2003
Patient nonadherence to medication in inflammatory bowel diseaseMaida J Sewitch, Michal Abrahamowicz, Alan Barkun, et al.
Journal of Crohn'S & Colitis|October 30, 2018
Reply to Letter on: 'Risk Factors Associated With Clostridium difficile Infection in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis'Bhairavi Balram, Robert Battat, Alex Al-Khoury, et al.
Public Health Genomics|August 17, 2017
Exploring the Use of a Participative Design in the Early Development of a Predictive Test: The Importance of Physician InvolvementSophie Veilleux, Maude Villeneuve, Nathalie Lachapelle, et al.
Journal of Crohn'S & Colitis|September 25, 2018
Risk Factors Associated with Clostridium difficile Infection in Inflammatory Bowel Disease: A Systematic Review and Meta-AnalysisBhairavi Balram, Robert Battat, Alex Al-Khoury, et al.
Inflammatory Bowel Diseases|October 24, 2008
Epidemiology of Crohn's disease in Québec, CanadaAnne-Marie Lowe, Pierre-Olivier Roy, Michel B-Poulin, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 3, 2017
Association Between Ustekinumab Trough Concentrations and Clinical, Biomarker, and Endoscopic Outcomes in Patients With Crohn's DiseaseRobert Battat, Uri Kopylov, Talat Bessissow, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|October 10, 2013
Overview of subsequent entry biologics for the management of inflammatory bowel disease and Canadian Association of Gastroenterology position statement on subsequent entry biologicsShane M Devlin, Brian Bressler, Charles N Bernstein, et al.
Saudi Journal of Gastroenterology : Official Journal of the Saudi Gastroenterology Association|March 23, 2019
Maladaptive coping, low self-efficacy and disease activity are associated with poorer patient-reported outcomes in inflammatory bowel diseaseChe-Yung Chao, Carolyne Lemieux, Sophie Restellini, et al.
Pageof 20